|
시장보고서
상품코드
1972957
성장인자 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Growth Factors Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 성장인자 시장 규모는 2026년 24억 달러에서 2033년까지 39억 달러로 대폭 성장하며, 견고한 CAGR 5.7%로 추이할 것으로 예측되고 있습니다. 이러한 성장은 주로 생명공학, 제약 연구, 재생의료 분야의 성장인자 채택 확대와 전 세계 만성질환 및 암 유병률 증가에 의해 주도되고 있습니다.
시장 개요
성장인자는 세포의 성장, 증식, 분화를 조절하는 천연 유래 단백질입니다. 상처 치유, 조직 재생, 표적 치료에 중요한 역할을 하고 있으며, 현대 생의학 연구 및 임상 응용에 필수적인 툴이 되고 있습니다. 종양학, 혈액학, 재생의학 분야에서의 범용성이 연구 및 치료 파이프라인 전반에 걸쳐 광범위한 채택을 촉진하고 있습니다.
재조합 DNA 기술 및 단백질 엔지니어링 등의 기술 발전으로 고순도 성장인자의 생산이 가능해져 연구 및 상업적 응용 분야에서 효능과 가용성이 향상되었습니다. 제약회사와 생명공학 기업의 단백질 기반 치료제에 대한 투자 증가는 시장 확대를 촉진하고 있습니다.
시장 성장 촉진요인
이 시장의 성장을 가속하는 요인은 다음과 같습니다.
- 1. 만성질환 및 암 발생률 증가: 전 세계에서 암, 심혈관질환, 당뇨병이 증가함에 따라 표적치료제 및 재생의료 솔루션의 중요성이 높아지면서 성장인자에 대한 수요가 증가하고 있습니다.
- 2. 세포치료 및 재생의료의 발전: 줄기세포 연구, 조직공학 및 체외 제조는 세포의 증식과 분화를 촉진하기 위해 성장인자가 필요하며, 이는 첨단 치료 응용 분야에서의 채택을 촉진하고 있습니다.
- 3. 정부 지원 및 자금 지원: 전 세계 규제 당국과 정부는 생명공학 및 재생의료 연구에 자금을 지원하고 있으며, 임상 및 연구 환경에서 성장인자의 사용을 촉진하고 있습니다.
- 4. 제약 분야 R&D 확대: 제약 및 바이오테크놀러지 기업은 단백질 기반 치료제에 대한 투자를 늘리고 있으며, R&D 프로그램 전반에 걸쳐 성장인자에 대한 수요를 강화하고 있습니다.
비즈니스 기회
성장인자 시장은 제조업체와 투자자들에게 여러 가지 유망한 기회를 제공
- 혁신적인 치료법: 성장인자는 재생의료, 암 치료, 상처 치유 제품 개발에 필수적이며, 연구개발과 상업화에 큰 기회를 창출하고 있습니다.
- 신흥 시장 성장: 아시아태평양 및 라틴아메리카의 의료 인프라 및 연구 구상의 확장은 시장 확대의 길을 열어줄 것입니다.
- 전략적 제휴 : 연구센터, CRO(의약품 개발 수탁기관), 학술기관과의 제휴를 통해 제품 개발의 가속화와 시장에서의 입지를 강화할 수 있습니다.
지역별 분석
- 북미: 강력한 제약-바이오 산업 기반, 탄탄한 연구 인프라, 첨단 치료법에 대한 정부 자금 지원으로 시장을 선도하고 있습니다.
- 유럽: 재생의료, 단백질 기반 치료제의 높은 채택률, 지원적인 규제 프레임워크에 힘입어 꾸준한 성장세를 보이고 있습니다.
- 아시아태평양: 의료비 지출 증가, 생명공학 생태계 성장, 중국, 일본, 인도의 연구 활동 확대로 인해 가장 빠른 성장률을 보일 것으로 예측됩니다.
- 라틴아메리카: 의료 인프라 개선, 세계 바이오 기업과의 협력 강화, 연구 역량 확대가 성장을 지원하고 있습니다.
- 아프리카: 규모는 작지만, 첨단 치료법에 대한 인지도 향상과 바이오테크놀러지 솔루션의 도입 확대로 시장이 꾸준히 확대되고 있습니다.
주요 진출 기업
시장은 경쟁이 치열하고, 주요 기업은 연구개발, 제품 개발, 상업화에 집중하고 있습니다. 주요 기업은 다음과 같습니다.
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Hoffmann-La Roche Ltd.
- Applied Biological Materials(abm), Inc.
- Abcam plc
- GE Healthcare
- Cell Signaling Technology, Inc.
- Meridian Bioscience Inc.
- Sartorius CellGenix GmbH
- Bio-Techne Corporation
- Proteintech Group, Inc.
- Miltenyi Biotec
- Creative Bioarray
- Akron Biotech
- Sino Biological Inc.
- Repligen Corporation
- LEADGENE BIOMEDICAL, INC.
- PeproTech Inc.
이들 기업은 안정성, 특이성, 치료용도가 강화된 차세대 성장인자 개발을 위해 포트폴리오 확대, 연구개발 투자, 전략적 제휴를 진행하고 있습니다.
시장 세분화
제품 유형별:
- 트랜스포밍 성장인자(TGF)
- 액티빈
- 골형성 단백질(BMP)
- TGF-베타 단백질
- 상피성장인자(EGFs)
- 혈소판 유래 성장인자(PDGF)
- 섬유아세포 성장인자(FGF)
- 인슐린 유사 성장인자(IGFs)
- 혈관내피성장인자(VEGF)
- 간세포증식인자(HGF)
- 종양괴사인자(TNF)
- 인터류킨
- 기타
용도별:
- 종양학
- 혈액학
- 상처 치유
- 피부과
- 심혈관 질환 및 당뇨병
- 세포치료 및 체외 제조
- 기타
최종사용자별:
- 제약회사 및 생명공학 기업
- 연구센터 및 학술기관
- 연구개발 수탁기관
지역별:
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 개요
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 촉진요인
- 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter's Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재의 가격과 향후 예측, 2025-2033년
- 가격 영향요인
제3장 세계 성장요인 시장 전망, 2020-2033년
- 세계의 성장요인 시장 전망, 제품 유형별, 금액(10억 달러), 2020-2033년
- TGF(Transforming Growth Factor)
- 상피 성장인자(EGF)
- 혈소판 유래 성장인자(PDGF)
- 섬유아세포 증식인자(FGF)
- 인슐린 유사 성장인자(IGF)
- 혈관내피세포 성장인자(VEGF)
- 간세포 증식인자(HGF)
- 종양괴사인자(TNF)
- 인터류킨
- 기타
- 세계의 성장요인 시장 전망, 애플리케이션별, 금액(10억 달러), 2020-2033년
- 종양학
- 혈액학
- 상처 치유
- 피부과
- 심혈관질환과 당뇨병
- 세포치료와 체외 제조
- 기타
- 세계의 성장요인 시장 전망, 최종사용자별, 금액(10억 달러), 2020-2033년
- 제약 및 바이오테크놀러지 기업
- 연구센터와 학술기관
- 계약 조사기관
- 세계의 성장요인 시장 전망, 지역별, 금액(10억 달러), 2020-2033년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미의 성장요인 시장 전망, 2020-2033년
제5장 유럽의 성장요인 시장 전망, 2020-2033년
제6장 아시아태평양의 성장요인 시장 전망, 2020-2033년
제7장 라틴아메리카의 성장요인 시장 전망, 2020-2033년
제8장 중동 및 아프리카의 성장요인 시장 전망, 2020-2033년
제9장 경쟁 구도
- 기업 대 부문 히트맵
- 기업 시장 점유율 분석, 2025년
- 경쟁 대시보드
- 기업 개요
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Hoffmann-La Roche Ltd.
- Applied Biological Materials(abm), Inc.
- Abcam plc
- GE Healthcare
- Cell Signaling Technology, Inc.
- Meridian Bioscience Inc.
- Sartorius CellGenix GmbH
제10장 부록
KSAThe global Growth Factors Market is anticipated to grow significantly, rising from $2.4 billion in 2026 to $3.9 billion by 2033, at a robust compound annual growth rate (CAGR) of 5.7%. This growth is primarily driven by the increasing adoption of growth factors in biotechnology, pharmaceutical research, and regenerative medicine, alongside the rising prevalence of chronic diseases and cancer worldwide.
Market Overview
Growth factors are naturally occurring proteins that regulate cellular growth, proliferation, and differentiation. They play a vital role in wound healing, tissue regeneration, and targeted therapeutics, making them essential tools in modern biomedical research and clinical applications. Their versatility in oncology, hematology, and regenerative medicine has driven widespread adoption across research and therapeutic pipelines.
Technological advancements, including recombinant DNA technology and protein engineering, have enabled the production of high-purity growth factors, improving their efficacy and availability for research and commercial applications. Increasing investments by pharmaceutical and biotechnology companies in protein-based therapeutics are further driving market expansion.
Market Drivers
Several factors are fueling growth in this market:
- 1. Rising Chronic Disease and Cancer Incidence: The global increase in cancer, cardiovascular disorders, and diabetes is boosting demand for growth factors as targeted therapies and regenerative solutions gain importance.
- 2. Advancements in Cell Therapy and Regenerative Medicine: Stem cell research, tissue engineering, and ex-vivo manufacturing require growth factors to enhance cell proliferation and differentiation, driving their adoption in advanced therapeutic applications.
- 3. Government Support and Funding: Regulatory agencies and governments worldwide are funding biotechnology and regenerative medicine research, promoting the use of growth factors in clinical and research settings.
- 4. Expansion of Pharmaceutical R&D: Pharmaceutical and biotechnology firms are increasingly investing in protein-based therapeutics, strengthening demand for growth factors across research and drug development programs.
Business Opportunities
The growth factors market presents several lucrative opportunities for manufacturers and investors:
- Innovative Therapeutics: Growth factors are critical to developing regenerative therapies, cancer treatments, and wound healing products, creating significant opportunities for research and commercialization.
- Emerging Market Growth: Increasing healthcare infrastructure and research initiatives in Asia Pacific and Latin America provide avenues for market expansion.
- Strategic Collaborations: Partnerships with research centers, contract research organizations (CROs), and academic institutions can accelerate product development and strengthen market presence.
Regional Analysis
- North America: Dominates the market due to a strong pharmaceutical and biotechnology ecosystem, well-established research infrastructure, and substantial government funding for advanced therapeutics.
- Europe: Experiences steady growth driven by high adoption of regenerative therapies, protein-based therapeutics, and supportive regulatory frameworks.
- Asia Pacific: Projected to grow at the fastest rate, fueled by increasing healthcare expenditure, a growing biotechnology ecosystem, and expanding research initiatives in China, Japan, and India.
- Latin America: Growth is supported by improving healthcare infrastructure, rising collaborations with global biotech firms, and expanding research capabilities.
- Middle East & Africa: Though smaller in size, the market is expanding steadily due to increasing awareness of advanced therapies and growing adoption of biotechnology-based solutions.
Key Players
The market is highly competitive, with key players focusing on research, product development, and commercialization. Leading companies include:
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Hoffmann-La Roche Ltd.
- Applied Biological Materials (abm), Inc.
- Abcam plc
- GE Healthcare
- Cell Signaling Technology, Inc.
- Meridian Bioscience Inc.
- Sartorius CellGenix GmbH
- Bio-Techne Corporation
- Proteintech Group, Inc.
- Miltenyi Biotec
- Creative Bioarray
- Akron Biotech
- Sino Biological Inc.
- Repligen Corporation
- LEADGENE BIOMEDICAL, INC.
- PeproTech Inc.
These companies are expanding portfolios, investing in R&D, and forming strategic collaborations to develop next-generation growth factors with enhanced stability, specificity, and therapeutic applications.
Market Segmentation
By Product Type:
- Transforming Growth Factor (TGF)
- Activin
- Bone Morphogenetic Proteins (BMPs)
- TGF-beta Proteins
- Epidermal Growth Factors (EGFs)
- Platelet-Derived Growth Factors (PDGFs)
- Fibroblast Growth Factors (FGFs)
- Insulin-like Growth Factors (IGFs)
- Vascular Endothelial Growth Factors (VEGFs)
- Hepatocyte Growth Factors (HGFs)
- Tumor Necrosis Factors (TNFs)
- Interleukins
- Others
By Application:
- Oncology
- Hematology
- Wound Healing
- Dermatology
- Cardiovascular Disease & Diabetes
- Cell Therapy and Ex-Vivo Manufacturing
- Others
By End User:
- Pharmaceutical and Biotechnology Companies
- Research Centres & Academic Institutes
- Contract Research Organisations
By Geographic Coverage:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Growth Factors Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Growth Factors Market Outlook, 2020-2033
- 3.1. Global Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Transforming Growth Factor (TGF)
- 3.1.1.1. Activin
- 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 3.1.1.3. TGF-beta Proteins
- 3.1.2. Epidermal Growth Factors (EGFs)
- 3.1.3. Platelet-Derived Growth Factors (PDGFs)
- 3.1.4. Fibroblast Growth Factors (FGFs)
- 3.1.5. Insulin-like Growth Factors (IGFs)
- 3.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 3.1.7. Hepatocyte Growth Factors (HGFs)
- 3.1.8. Tumor Necrosis Factors (TNFs)
- 3.1.9. Interleukins
- 3.1.10. Others
- 3.1.1. Transforming Growth Factor (TGF)
- 3.2. Global Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Oncology
- 3.2.2. Hematology
- 3.2.3. Wound Healing
- 3.2.4. Dermatology
- 3.2.5. Cardiovascular Disease & Diabetes
- 3.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 3.2.7. Others
- 3.3. Global Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.3.1. Pharmaceutical and Biotechnology Companies
- 3.3.2. Research Centres & Academic Institutes
- 3.3.3. Contract Research Organisations
- 3.4. Global Growth Factors Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Growth Factors Market Outlook, 2020-2033
- 4.1. North America Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Transforming Growth Factor (TGF)
- 4.1.1.1. Activin
- 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 4.1.1.3. TGF-beta Proteins
- 4.1.2. Epidermal Growth Factors (EGFs)
- 4.1.3. Platelet-Derived Growth Factors (PDGFs)
- 4.1.4. Fibroblast Growth Factors (FGFs)
- 4.1.5. Insulin-like Growth Factors (IGFs)
- 4.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 4.1.7. Hepatocyte Growth Factors (HGFs)
- 4.1.8. Tumor Necrosis Factors (TNFs)
- 4.1.9. Interleukins
- 4.1.10. Others
- 4.1.1. Transforming Growth Factor (TGF)
- 4.2. North America Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Oncology
- 4.2.2. Hematology
- 4.2.3. Wound Healing
- 4.2.4. Dermatology
- 4.2.5. Cardiovascular Disease & Diabetes
- 4.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 4.2.7. Others
- 4.3. North America Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.3.1. Pharmaceutical and Biotechnology Companies
- 4.3.2. Research Centres & Academic Institutes
- 4.3.3. Contract Research Organisations
- 4.4. North America Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Growth Factors Market Outlook, by Product Type, 2020-2033
- 4.4.2. U.S. Growth Factors Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Growth Factors Market Outlook, by End User, 2020-2033
- 4.4.4. Canada Growth Factors Market Outlook, by Product Type, 2020-2033
- 4.4.5. Canada Growth Factors Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Growth Factors Market Outlook, by End User, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Growth Factors Market Outlook, 2020-2033
- 5.1. Europe Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Transforming Growth Factor (TGF)
- 5.1.1.1. Activin
- 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 5.1.1.3. TGF-beta Proteins
- 5.1.2. Epidermal Growth Factors (EGFs)
- 5.1.3. Platelet-Derived Growth Factors (PDGFs)
- 5.1.4. Fibroblast Growth Factors (FGFs)
- 5.1.5. Insulin-like Growth Factors (IGFs)
- 5.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 5.1.7. Hepatocyte Growth Factors (HGFs)
- 5.1.8. Tumor Necrosis Factors (TNFs)
- 5.1.9. Interleukins
- 5.1.10. Others
- 5.1.1. Transforming Growth Factor (TGF)
- 5.2. Europe Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Oncology
- 5.2.2. Hematology
- 5.2.3. Wound Healing
- 5.2.4. Dermatology
- 5.2.5. Cardiovascular Disease & Diabetes
- 5.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 5.2.7. Others
- 5.3. Europe Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.3.1. Pharmaceutical and Biotechnology Companies
- 5.3.2. Research Centres & Academic Institutes
- 5.3.3. Contract Research Organisations
- 5.4. Europe Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.2. Germany Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.4. Italy Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.5. Italy Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.7. France Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.8. France Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.9. France Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.10. U.K. Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.11. U.K. Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.13. Spain Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.14. Spain Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.16. Russia Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.17. Russia Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Growth Factors Market Outlook, by End User, 2020-2033
- 5.4.19. Rest of Europe Growth Factors Market Outlook, by Product Type, 2020-2033
- 5.4.20. Rest of Europe Growth Factors Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Growth Factors Market Outlook, by End User, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Growth Factors Market Outlook, 2020-2033
- 6.1. Asia Pacific Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Transforming Growth Factor (TGF)
- 6.1.1.1. Activin
- 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 6.1.1.3. TGF-beta Proteins
- 6.1.2. Epidermal Growth Factors (EGFs)
- 6.1.3. Platelet-Derived Growth Factors (PDGFs)
- 6.1.4. Fibroblast Growth Factors (FGFs)
- 6.1.5. Insulin-like Growth Factors (IGFs)
- 6.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 6.1.7. Hepatocyte Growth Factors (HGFs)
- 6.1.8. Tumor Necrosis Factors (TNFs)
- 6.1.9. Interleukins
- 6.1.10. Others
- 6.1.1. Transforming Growth Factor (TGF)
- 6.2. Asia Pacific Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Oncology
- 6.2.2. Hematology
- 6.2.3. Wound Healing
- 6.2.4. Dermatology
- 6.2.5. Cardiovascular Disease & Diabetes
- 6.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 6.2.7. Others
- 6.3. Asia Pacific Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.3.1. Pharmaceutical and Biotechnology Companies
- 6.3.2. Research Centres & Academic Institutes
- 6.3.3. Contract Research Organisations
- 6.4. Asia Pacific Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.2. China Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.3. China Growth Factors Market Outlook, by End User, 2020-2033
- 6.4.4. Japan Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.5. Japan Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Growth Factors Market Outlook, by End User, 2020-2033
- 6.4.7. South Korea Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.8. South Korea Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Growth Factors Market Outlook, by End User, 2020-2033
- 6.4.10. India Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.11. India Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.12. India Growth Factors Market Outlook, by End User, 2020-2033
- 6.4.13. Southeast Asia Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.14. Southeast Asia Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Growth Factors Market Outlook, by End User, 2020-2033
- 6.4.16. Rest of SAO Growth Factors Market Outlook, by Product Type, 2020-2033
- 6.4.17. Rest of SAO Growth Factors Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Growth Factors Market Outlook, by End User, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Growth Factors Market Outlook, 2020-2033
- 7.1. Latin America Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Transforming Growth Factor (TGF)
- 7.1.1.1. Activin
- 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 7.1.1.3. TGF-beta Proteins
- 7.1.2. Epidermal Growth Factors (EGFs)
- 7.1.3. Platelet-Derived Growth Factors (PDGFs)
- 7.1.4. Fibroblast Growth Factors (FGFs)
- 7.1.5. Insulin-like Growth Factors (IGFs)
- 7.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 7.1.7. Hepatocyte Growth Factors (HGFs)
- 7.1.8. Tumor Necrosis Factors (TNFs)
- 7.1.9. Interleukins
- 7.1.10. Others
- 7.1.1. Transforming Growth Factor (TGF)
- 7.2. Latin America Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Oncology
- 7.2.2. Hematology
- 7.2.3. Wound Healing
- 7.2.4. Dermatology
- 7.2.5. Cardiovascular Disease & Diabetes
- 7.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 7.2.7. Others
- 7.3. Latin America Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.3.1. Pharmaceutical and Biotechnology Companies
- 7.3.2. Research Centres & Academic Institutes
- 7.3.3. Contract Research Organisations
- 7.4. Latin America Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Growth Factors Market Outlook, by Product Type, 2020-2033
- 7.4.2. Brazil Growth Factors Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Growth Factors Market Outlook, by End User, 2020-2033
- 7.4.4. Mexico Growth Factors Market Outlook, by Product Type, 2020-2033
- 7.4.5. Mexico Growth Factors Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Growth Factors Market Outlook, by End User, 2020-2033
- 7.4.7. Argentina Growth Factors Market Outlook, by Product Type, 2020-2033
- 7.4.8. Argentina Growth Factors Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Growth Factors Market Outlook, by End User, 2020-2033
- 7.4.10. Rest of LATAM Growth Factors Market Outlook, by Product Type, 2020-2033
- 7.4.11. Rest of LATAM Growth Factors Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Growth Factors Market Outlook, by End User, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Growth Factors Market Outlook, 2020-2033
- 8.1. Middle East & Africa Growth Factors Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Transforming Growth Factor (TGF)
- 8.1.1.1. Activin
- 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
- 8.1.1.3. TGF-beta Proteins
- 8.1.2. Epidermal Growth Factors (EGFs)
- 8.1.3. Platelet-Derived Growth Factors (PDGFs)
- 8.1.4. Fibroblast Growth Factors (FGFs)
- 8.1.5. Insulin-like Growth Factors (IGFs)
- 8.1.6. Vascular Endothelial Growth Factors (VEGFs)
- 8.1.7. Hepatocyte Growth Factors (HGFs)
- 8.1.8. Tumor Necrosis Factors (TNFs)
- 8.1.9. Interleukins
- 8.1.10. Others
- 8.1.1. Transforming Growth Factor (TGF)
- 8.2. Middle East & Africa Growth Factors Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Oncology
- 8.2.2. Hematology
- 8.2.3. Wound Healing
- 8.2.4. Dermatology
- 8.2.5. Cardiovascular Disease & Diabetes
- 8.2.6. Cell Therapy and Ex-Vivo Manufacturing
- 8.2.7. Others
- 8.3. Middle East & Africa Growth Factors Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.3.1. Pharmaceutical and Biotechnology Companies
- 8.3.2. Research Centres & Academic Institutes
- 8.3.3. Contract Research Organisations
- 8.4. Middle East & Africa Growth Factors Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Growth Factors Market Outlook, by Product Type, 2020-2033
- 8.4.2. GCC Growth Factors Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Growth Factors Market Outlook, by End User, 2020-2033
- 8.4.4. South Africa Growth Factors Market Outlook, by Product Type, 2020-2033
- 8.4.5. South Africa Growth Factors Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Growth Factors Market Outlook, by End User, 2020-2033
- 8.4.7. Egypt Growth Factors Market Outlook, by Product Type, 2020-2033
- 8.4.8. Egypt Growth Factors Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Growth Factors Market Outlook, by End User, 2020-2033
- 8.4.10. Nigeria Growth Factors Market Outlook, by Product Type, 2020-2033
- 8.4.11. Nigeria Growth Factors Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Growth Factors Market Outlook, by End User, 2020-2033
- 8.4.13. Rest of Middle East Growth Factors Market Outlook, by Product Type, 2020-2033
- 8.4.14. Rest of Middle East Growth Factors Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Growth Factors Market Outlook, by End User, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Lonza Group AG
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Thermo Fisher Scientific Inc.
- 9.4.3. Merck KGaA
- 9.4.4. Hoffmann-La Roche Ltd.
- 9.4.5. Applied Biological Materials (abm), Inc.
- 9.4.6. Abcam plc
- 9.4.7. GE Healthcare
- 9.4.8. Cell Signaling Technology, Inc.
- 9.4.9. Meridian Bioscience Inc.
- 9.4.10. Sartorius CellGenix GmbH
- 9.4.1. Lonza Group AG
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
샘플 요청 목록